跳至主要内容
临床试验/NCT02804464
NCT02804464进行中(未招募)不适用

The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)

Karius, Inc.1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2016年7月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Karius, Inc.
入组人数
70
试验地点
1
主要终点
Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics.

研究概览

简要总结

Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Patients who plan on undergoing an allogeneic stem cell transplant and are admitted to UCSF Medical Center.

排除标准

  • Inability to provide informed consent and comply with study-related procedures

结局指标

主要结局

Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics.

时间窗: 7 days

次要结局

未报告次要终点

研究者

发起方
Karius, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验